{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:40:53Z","timestamp":1779939653206,"version":"3.53.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>To delineate the characteristics and treatment of cytomegalovirus-immune recovery retinitis (CMV-IRR) in human immunodeficiency virus (HIV) patients with immune recovery under effective highly active antiretroviral therapy (HAART) regimen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We reported four patients with HIV who were diagnosed with CMV-IRR soon after effective HAART. Plasma levels of CD4 T cells, HAART regimen, and other clinical and laboratory characteristics of the four patients were described. Patients were monitored for ocular manifestations and clinical signs under effective ocular and systemic anti-cytomegalovirus (CMV) and corticosteroid treatment for 12 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>With HAART, plasma levels of CD4 T cell counts rose remarkably. The mean baseline CD4 count of the four patients was 14.5 (range from 7 to 33) cells\/\u03bcl before HAART and 183.25 (range from 153 to 220) cells\/\u03bcl when diagnosed with CMV-IRR. Ophthalmic examination demonstrated severe vitreous opacities and necrotizing retinitis, intraretinal hemorrhages, and vasculitis. A large number of CMV sequencing was detected by DNA sequencing of vitreous samples. All four patients were recovered from CMV-IRR with anti-CMV and corticosteroid treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Cytomegalovirus-immune recovery retinitis is a new diagnosis of HIV-associated ocular complication under HAART. These findings suggest that the immunological effects of HAART may accelerate the CMV retinitis in patients with very low initial CD4 T cell counts. HIV patients are recommended to have a thorough fundus examination before HAART initiation and a close follow-up especially in those with low CD4 counts to avoid the progression of CMV retinitis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.807013","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T05:55:09Z","timestamp":1651038909000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Cytomegalovirus-Immune Recovery Retinitis After Initiation of Highly Active Antiretroviral Therapy: A Case Series"],"prefix":"10.3389","volume":"9","author":[{"given":"Yiwen","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoziyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinshan","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhou","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/HIV.S42328","article-title":"Immune reconstitution inflammatory syndrome in HIV-infected patients","volume":"7","author":"Walker","year":"2015","journal-title":"HIV AIDS."},{"key":"B2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2298\/SARH0710513D","volume":"135","author":"Dujic","year":"2007","journal-title":"Srp Arh Celok Lek."},{"key":"B3","doi-asserted-by":"publisher","first-page":"971417","DOI":"10.1155\/2014\/971417","article-title":"Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment","volume":"2014","author":"Urban","year":"2014","journal-title":"Mediat Inflamm."},{"key":"B4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/cid\/ciu291","article-title":"Proposed clinical case definition for cytomegalovirus-immune recovery retinitis","volume":"59","author":"Ruiz-Cruz","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/bjo.85.7.837","article-title":"CMVR diagnoses and progression of CD4 cell counts and HIV viral load measurements in HIV patients on HAART","volume":"85","author":"Zambarakji","year":"2001","journal-title":"Brit J Ophthalmol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/00006982-200602000-00007","article-title":"Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis","volume":"26","author":"Schrier","year":"2006","journal-title":"Retina."},{"key":"B7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","article-title":"Standardization of vitreal inflammatory activity in intermediate and posterior uveitis","volume":"92","author":"Nussenblatt","year":"1985","journal-title":"Ophthalmology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S0140-6736(05)63176-5","article-title":"Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy","volume":"350","author":"Stein","year":"1997","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00006982-200108000-00007","article-title":"Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-term results in a small case series","volume":"21","author":"Reed","year":"2001","journal-title":"Retina."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1167\/iovs.18-26517","article-title":"Relationship between opacity of cytomegalovirus retinitis lesion borders and severity of immunodeficiency among people with AIDS","volume":"60","author":"Holland","year":"2019","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0161-6420(00)00023-3","article-title":"Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis","volume":"107","author":"Macdonald","year":"2000","journal-title":"Ophthalmology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1086\/517399","article-title":"Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients","volume":"177","author":"Tural","year":"1998","journal-title":"J Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1086\/314710","article-title":"Cytomegalovirus (CMV) retinitis activity is accurately reflected by the presence and level of CMV DNA in aqueous humor and vitreous","volume":"179","author":"Smith","year":"1999","journal-title":"J Infect Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ophtha.2005.10.067","article-title":"Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis","volume":"113","author":"Kempen","year":"2006","journal-title":"Ophthalmology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/archopht.116.2.169","article-title":"Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome","volume":"116","author":"Karavellas","year":"1998","journal-title":"Arch Ophthalmol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1086\/314639","article-title":"Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy","volume":"179","author":"Karavellas","year":"1999","journal-title":"J Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1869-5760-3-2","article-title":"Ocular lesions in 1,000 consecutive HIV-positive patients in India: a long-term study","volume":"3","author":"Sudharshan","year":"2013","journal-title":"J Ophthalmic Inflamm Infect."},{"key":"B18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0002-9394(00)00530-4","article-title":"Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy","volume":"130","author":"Robinson","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"B19","first-page":"S15","article-title":"Treatment of cytomegalovirus retinitis in AIDS patients with intravitreal ganciclovir","volume":"88","author":"Ausayakhun","year":"2005","journal-title":"J Med Assoc Thai."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00417-014-2587-5","article-title":"Outcome of cytomegalovirus retinitis in immunocompromised patients without Human Immunodeficiency Virus treated with intravitreal ganciclovir injection","volume":"252","author":"Agarwal","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"ofz439","DOI":"10.1093\/ofid\/ofz439","article-title":"Cytomegalovirus retinitis screening and treatment in human immunodeficiency virus patients in Malawi: a feasibility study","volume":"6","author":"Ocieczek","year":"2019","journal-title":"Open Forum Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12879-016-1490-6","article-title":"Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis","volume":"16","author":"Choopong","year":"2016","journal-title":"BMC Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.18240\/ijo.2019.08.19","article-title":"Effect of individualized therapy for AIDS patients with cytomegalovirus retinitis in intravitreal ganciclovir injections","volume":"12","author":"Xie","year":"2019","journal-title":"Int J Ophthalmol."},{"key":"B24","first-page":"S63","article-title":"The high-dose, alternate-week intravitreal ganciclovir injections for cytomegalovirus retinitis in acquired immune deficiency syndrome patients on highly active antiretroviral therapy","volume":"88","author":"Yutthitham","year":"2005","journal-title":"J Med Assoc Thai."},{"key":"B25","first-page":"38","article-title":"Managing CMV retinitis in the developing world","volume":"16","author":"Visser","year":"2003","journal-title":"Community Eye Health"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006982-200102000-00001","article-title":"Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, treatment outcomes","volume":"21","author":"Karavellas","year":"2001","journal-title":"Retina."},{"key":"B27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/00006982-200406000-00007","article-title":"Long-term results of treatment of macular complications in eyes with immune recovery uveitis using a graded treatment approach","volume":"24","author":"El-Bradey","year":"2004","journal-title":"Retina."},{"key":"B28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/bjo.83.5.540","article-title":"Treatment of immune recovery vitritis with local steroids","volume":"83","author":"Henderson","year":"1999","journal-title":"Brit J Ophthalmol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ajo.2007.12.001","article-title":"AIDS and ophthalmology: the first quarter century","volume":"145","author":"Holland","year":"2008","journal-title":"Am J Ophthalmol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.ophtha.2010.03.031","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes","volume":"117","author":"Jabs","year":"2010","journal-title":"Ophthalmology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/eye.2011.327","article-title":"Cytomegalovirus and the eye","volume":"26","author":"Carmichael","year":"2012","journal-title":"Eye"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.807013\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T05:55:28Z","timestamp":1651038928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.807013\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":31,"alternative-id":["10.3389\/fmed.2022.807013"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.807013","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,27]]},"article-number":"807013"}}